TW200609221A - 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them - Google Patents

4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them

Info

Publication number
TW200609221A
TW200609221A TW094120002A TW94120002A TW200609221A TW 200609221 A TW200609221 A TW 200609221A TW 094120002 A TW094120002 A TW 094120002A TW 94120002 A TW94120002 A TW 94120002A TW 200609221 A TW200609221 A TW 200609221A
Authority
TW
Taiwan
Prior art keywords
intermediates
preparation
pharmaceutical compositions
compositions containing
quinoline derivatives
Prior art date
Application number
TW094120002A
Other languages
English (en)
Inventor
Michel Tabart
Fabrice Viviani
Serge Mignani
Baptiste Ronan
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of TW200609221A publication Critical patent/TW200609221A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
TW094120002A 2004-06-29 2005-06-16 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them TW200609221A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0407124A FR2872164B1 (fr) 2004-06-29 2004-06-29 Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
TW200609221A true TW200609221A (en) 2006-03-16

Family

ID=34954685

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094120002A TW200609221A (en) 2004-06-29 2005-06-16 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them

Country Status (12)

Country Link
US (1) US20080032985A1 (zh)
EP (1) EP1763527A1 (zh)
JP (1) JP2008504351A (zh)
KR (1) KR20070029763A (zh)
CN (1) CN101023076A (zh)
AU (1) AU2005266218A1 (zh)
CA (1) CA2571668A1 (zh)
EA (1) EA200700166A1 (zh)
FR (1) FR2872164B1 (zh)
IL (1) IL179709A0 (zh)
TW (1) TW200609221A (zh)
WO (1) WO2006010831A1 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006002047A2 (en) 2004-06-15 2006-01-05 Glaxo Group Limited Antibacterial agents
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
JP2009532423A (ja) 2006-04-06 2009-09-10 グラクソ グループ リミテッド 抗菌剤としてのピロロ−キノキサリノン誘導体
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
CL2008001003A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008001002A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
US8389524B2 (en) * 2007-04-20 2013-03-05 Glaxo Group Limited Tricyclic nitrogen containing compounds as antibacterial agents
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
WO2009128019A1 (en) 2008-04-15 2009-10-22 Actelion Pharmaceuticals Ltd Tricyclic antibiotics
US20110275661A1 (en) 2008-10-17 2011-11-10 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
US8318940B2 (en) 2009-01-15 2012-11-27 Glaxo Group Limited Naphthyridin-2 (1 H)-one compounds useful as antibacterials
PE20170501A1 (es) 2014-08-22 2017-04-27 Glaxosmithkline Ip Dev Ltd Un procedimiento que comprende compuestos que administran a un sujeto infectado con neisseria gonorrhoeae
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
EP0991623A2 (en) * 1997-06-19 2000-04-12 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
AU2437900A (en) * 1999-01-20 2000-08-07 Smithkline Beecham Plc Piperidinylquinolines as protein tyrosine kinase inhibitors
HUP0300721A3 (en) * 2000-07-26 2006-02-28 Smithkline Beecham Plc Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity, process for producing them, pharmaceutical compositions containing them and use thereof
FR2858619B1 (fr) * 2003-08-08 2006-12-22 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
FR2872164B1 (fr) 2006-11-17
CN101023076A (zh) 2007-08-22
AU2005266218A1 (en) 2006-02-02
IL179709A0 (en) 2007-05-15
WO2006010831A1 (fr) 2006-02-02
EP1763527A1 (fr) 2007-03-21
AU2005266218A2 (en) 2006-02-02
US20080032985A1 (en) 2008-02-07
KR20070029763A (ko) 2007-03-14
FR2872164A1 (fr) 2005-12-30
CA2571668A1 (en) 2006-02-02
EA200700166A1 (ru) 2007-06-29
JP2008504351A (ja) 2008-02-14

Similar Documents

Publication Publication Date Title
TW200609221A (en) 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
MXPA05012026A (es) Compuestos de azaindol como inhibidores de cinasa.
WO2009111653A3 (en) Antiviral therapeutic agents
MXPA05012025A (es) Imidazo y tiazolopiridinas como inhibidores de cinasa jak3.
MY148634A (en) Pyridazinone derivatives
TW200833675A (en) Nicotinamide derivatives
TW200732323A (en) Organic compounds
JO2770B1 (en) Organic compounds
WO2009024611A3 (en) 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use
TW200621729A (en) Pyrimidine derivatives
SE0101675D0 (sv) Novel composition
WO2008030744A3 (en) Inhibitors of c-met and uses thereof
WO2009082152A3 (en) Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
NO20072963L (no) 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere
MX2008002805A (es) Derivados de carboxamida como antagonistas del receptor muscarinico.
MX2007005475A (es) Metabolitos de ciertos derivados de [1,4] diazepino [6,7,1-ij] quinolina y metodos de preparacion y uso de los mismos.
MX2009000768A (es) Lactamas macrociclicas.
MA32479B1 (fr) Compoés nouveaux actifs comme antagonistes des recepteurs muscariniques
TW200740729A (en) Methods for preparing glutamic acid derivatives
WO2008033935A3 (en) Vinorelbine derivatives
DE602007005387D1 (de) Ptors
WO2009034432A8 (en) Novel compounds active as muscarinic receptor antagonists
WO2007000655A3 (en) Novel pyrazolopyrimidinone derivatives
GEP20094745B (en) Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same
WO2006097809A3 (en) Novel tyrosine derivatives